NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
Decibel Therapeutics
Presage Biosciences
Livzon Pharmaceutical Group Inc.
Advance Biofactures Corporation
Duke University
University of Florida
Brigham and Women's Hospital
University of Oklahoma